2024
Multilevel Implementation Strategies for Adolescent Human Papillomavirus Vaccine Uptake
Rutten L, Griffin J, St. Sauver J, MacLaughlin K, Austin J, Jenkins G, Herrin J, Jacobson R. Multilevel Implementation Strategies for Adolescent Human Papillomavirus Vaccine Uptake. JAMA Pediatrics 2024, 178: 29-36. PMID: 37983062, PMCID: PMC10957109, DOI: 10.1001/jamapediatrics.2023.4932.Peer-Reviewed Original ResearchConceptsAudit/feedbackReminder/recallHPV vaccine uptakeUsual careHPV vaccinationHPV vaccineVaccine uptakeHuman papillomavirusNational public health goalsHuman papillomavirus vaccine uptakeMultilevel implementation strategyHPV vaccination ratesPrimary care practicesHealth care professionalsEvidence-based interventionsPublic health goalsEvidence-based strategiesAdolescent vaccinesEligible patientsNew cancersPatient receiptVaccination ratesEligible childrenClinical trialsMayo Clinic
2018
Evaluating the impact of multilevel evidence-based implementation strategies to enhance provider recommendation on human papillomavirus vaccination rates among an empaneled primary care patient population: a study protocol for a stepped-wedge cluster randomized trial
Finney Rutten LJ, Radecki Breitkopf C, St. Sauver JL, Croghan IT, Jacobson DJ, Wilson PM, Herrin J, Jacobson RM. Evaluating the impact of multilevel evidence-based implementation strategies to enhance provider recommendation on human papillomavirus vaccination rates among an empaneled primary care patient population: a study protocol for a stepped-wedge cluster randomized trial. Implementation Science 2018, 13: 96. PMID: 30001723, PMCID: PMC6043954, DOI: 10.1186/s13012-018-0778-x.Peer-Reviewed Original ResearchConceptsHPV vaccination ratesEvidence-based implementation strategiesStepped-wedge clusterVaccination ratesIntervention 1Human papillomavirusIntervention 2Human papillomavirus (HPV) vaccination ratesPrimary care patient populationPrimary care sitesProvider-level interventionsPractice-level interventionProcess evaluationAdolescent vaccinesBackgroundEach yearHPV vaccineMale patientsPrimary outcomePediatric populationPatient numbersPatient populationProvider recommendationStudy protocolClinical trialsBlock randomization